One year in review 2018: ultrasonography in rheumatoid arthritis and psoriatic arthritis A. Zabotti, P. Mandl, G. Zampogna, C. Dejaco, A. Iagnocco
Full Papers
CER10579 2018,36,4 Pg. 0526-0532
Free to view
Appropriate cardiovascular disease risk assessment in systemic lupus erythematosus may be lacking in rheumatology practice F. Esmaeilbeigi, J.E. Pope
CER10668 2018,36,4 Pg. 0533-0539
Free to view
Serum aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1), a novel disease activity predictive biomarker of systemic lupus erythematosus S.S. Ahn, S.H. Hong, Y. Park, S.M. Jung, J.J. Song, Y.-B. Park, S.-W. Lee, S.G. Park
CER10751 2018,36,4 Pg. 0540-0544
Free to view
Increased circulating CD14brightCD16+ intermediate monocytes are regulated by TNF-α and IL-6 axis in accordance with disease activity in patients with rheumatoid arthritis M. Tsukamoto, K. Suzuki, N. Seta, T. Takeuchi
CER10569 2018,36,4 Pg. 0545-0551
Free to view
Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus T.K. Mcghie, P. Harvey, J. Su, N. Anderson, G. Tomlinson, Z. Touma
CER10765 2018,36,4 Pg. 0552-0558
Free to view
Predict rheumatoid arthritis conversion from undifferentiated arthritis with dynamic contrast-enhanced MRI and laboratory indexes X. Lei, H. Li, Y. Zhan, J. Qu
CER10810 2018,36,4 Pg. 0559-0567
Free to view
The Janus kinase inhibitor tofacitinib inhibits TNF-α-induced gliostatin expression in rheumatoid fibroblast-like synoviocytes Y. Kawaguchi, Y. Waguri-Nagaya, N. Tatematsu, Y. Oguri, M. Kobayashi, M. Nozaki, K. Asai, M. Aoyama, T. Otsuka
CER10693 2018,36,4 Pg. 0568-0574
Free to view
IL-6 receptor inhibition modulates type III collagen and C-reactive protein degradation in rheumatoid arthritis patients with an inadequate response to anti-tumour necrosis factor therapy: analysis of connective tissue turnover in the tocilizumab RADIATE P. Juhl, C.S. Thudium, N.S. Gudmann, M.A. Karsdal, A.-C. Bay-Jensen, A.S. Siebuhr
CER10729 2018,36,4 Pg. 0575-0580
Free to view
Self-reported childhood maltreatment, lifelong traumatic events and mental disorders in American and Israeli rheumatoid arthritis patients R. Merdler-Rabinowicz, A. Hassidim, R. Hellou, I. Merdler, W. Hauser, J.N. Ablin
CER10752 2018,36,4 Pg. 0581-0588
Free to view
Functional characterisation of ADP ribosylation factor-like protein 15 in rheumatoid arthritis synovial fibroblasts S. Kashyap, U. Kumar, A.K. Pandey, M. Kanjilal, P. Chattopadhyay, C. Yadav, B. Thelma
CER10787 2018,36,4 Pg. 0589-0594
Free to view
Socio-economic inequalities in occurrence and health care costs in rheumatic and musculoskeletal diseases: results from a Spanish population-based study including 1.9 million persons P. Putrik, S. Ramiro, J.F. Orueta, A. Keszei, E. Alonso Moran, R. Nuño Solinis, A. Boonen
CER10709 2018,36,4 Pg. 0595-0602
Free to view
Comparative effectiveness of glucosamine, chondroitin, acetaminophen or celecoxib for the treatment of knee and/or hip osteoarthritis: a network meta-analysis
X. Zhu, D. Wu, L. Sang, Y. Wang, Y. Shen, X. Zhuang, M. Chu, L. Jiang
CER10748 2018,36,4 Pg. 0603-0611
Free to view
Hypoalbuminaemia in antineutrophil cytoplasmic antibody-associated vasculitis: incidence and significance P.-C. Xu, Z.-Y. Tong, T. Chen, S. Gao, S.-Y. Hu, X.-W. Yang, T.-K. Yan, S. Lin
CER10788 2018,36,4 Pg. 0612-0618
Free to view
Serum IgG ACPA-IgM RF immune complexes were detected in rheumatoid arthritis patients positive for IgM ACPA A. Haraguchi, H. Yamada, M. Kondo, K. Okazaki, J.-I. Fukushi, A. Oyamada, Y. Yoshikai, Y. Nakashima
CER10700 2018,36,4 Pg. 0619-0626
Free to view
Rheumatoid arthritis patients achieved better quality of life than systemic lupus erythematosus patients at sustained remission V. Pascual-Ramos, I. Contreras-Yáñez, K.R. Valencia-Quiñones, J. Romero-Díaz
CER10730 2018,36,4 Pg. 0627-0635
Free to view
Association of depression with socioeconomic status, anticardiolipin antibodies, and organ damage in patients with systemic lupus erythematosus: results from the KORNET registry D.-J. Park, J.-H. Kang, K.-E. Lee, S.W. Kang, S.-K. Kwok, S.-K. Kim, J.-Y. Choe, H.-A. Kim, Y.-K. Sung, K. Shin, S.-I. Lee, C.-H. Lee, S.-J. Choi, S.-S. Lee
CER10853 2018,36,4 Pg. 0636-0642
Free to view
Cause-specific mortality in a large population-based cohort of patients with rheumatoid arthritis in Italy F. Ometto, U. Fedeli, E. Schievano, C. Botsios, L. Punzi, M.C. Corti
Brief Papers
CER10680 2018,36,4 Pg. 0643-0647
Free to view
Successful sequential therapy with rituximab and belimumab in patients with active systemic lupus erythematosus: a case series R. Gualtierotti, M.O. Borghi, M. Gerosa, T. Schioppo, P. Larghi, J. Geginat, P.L. Meroni
CER10980 2018,36,4 Pg. 0648-0651
Free to view
Interstitial lung disease in patients with mixed connective tissue disease: pilot study on predictors of lung involvement N. Narula, T. Narula, I. Mira-Avendano, B. Wang, A. Abril
Reviews
CER10591 2018,36,4 Pg. 0652-0657
Free to view
Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review N. Palmou-Fontana, V. Calvo-Río, J.L. Martín-Varillas, C. Fernández-Díaz, M. Mesquida, A. Adán, M.V. Hernández, M. Cordero-Coma, O. Maiz Alonso, D. Díaz-Valle, C. Fernández-Cid, O. Ruiz-Moreno, J.L. Hernández, M.A. González-Gay, R. Blanco
CER10332 2018,36,4 Pg. 0658-0667
Free to view
Effects of biologic disease-modifying anti-rheumatic drugs on the radiographic progression of rheumatoid arthritis: a systematic literature review B. Combe, S. Lula, C. Boone, P. Durez
Paediatric Rheumatology
CER10698 2018,36,4 Pg. 0668-0675
Free to view
Efficacy and safety of canakinumab in patients with Still’s disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups E. Feist, P. Quartier, B. Fautrel, R. Schneider, P. Sfriso, P. Efthimiou, L. Cantarini, K. Lheritier, K. Leon, C.S. Karyekar, A. Speziale
CER10561 2018,36,4 Pg. 0676-0682
Free to view
Intraarticular infliximab therapy in patients with juvenile idiopathic arthritis: the role of musculoskeletal ultrasound and disease activity scores in monitoring therapy response M. Vidovic, L. Lamot, M. Lamot, M. Harjacek
Letters to the Editor
CER11196 2018,36,4 Pg. 0683-0684
Free to view
Successful treatment with tofacitinib for renal disorder due to amyloid A amyloidosis and immunoglobulin A nephropathy in a patient with rheumatoid arthritis T. Watanabe, T. Hattori, Y. Ogawa, S. Jodo
CER10747 2018,36,4 Pg. 0685
Free to view
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept S. Piantoni, F. Regola, M. Scarsi, A. Tincani, P. Airò
CER11083 2018,36,4 Pg. 0686
Free to view
Successful treatment of a patient with both systemic lupus erythematosus and progressive hepatitis C using immunosuppressive therapy and interferon beta Y. Sugimori, H. Yamashita, H. Yorifuji, Y. Takahashi, H. Kaneko, A. Mimori
CER11063 2018,36,4 Pg. 0687
Free to view
Systemic lupus erythematosus in PubMed: a review of the articles published in 2016 J. Jiménez Alonso, J.A. Vargas Hitos, M. Zamora Pasadas, N. Navarrete Navarrete, L. Jáimez, J.M. Sabio
Erratum Corrige
CER11552 2018,36,4 Pg. 0688
Free to view
Erratum corrige: “Autologous peripheral blood haematopoietic stem cell transplantation for systemic lupus erythematosus:
the observation of long-term outcomes in a Chinese centre”. C. Cao et al. C. Cao, M. Wang, J. Sun, X. Peng, Q. Liu, L. Huang, Y. Chai, K. Lai, P. Chen, Q. Liu, Q. Li, Y. Peng, H. Xiong, J. Zhang, M. Chen, K. Zeng
Meeting Abstracts
CER11584 2018,36,4 Pg. 0689-0757
Free to view
Eleventh International Congress on Spondyloarthritides M. Breban, H. Marzo-Ortega, D. Elewaut, F. Van Den Bosch 4-6 October 2018, Gent, Belgium